Samuel Bengio
Directeur/Bestuurslid bij Biocortech SAS
Oorsprong van het eerstegraads netwerk van Samuel Bengio
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France.
4
| Private Company | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Samuel Bengio via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Ecole Centrale Lyon | College/University | Doctorate Degree | |
University of Lyon | College/University | Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Ipsen Ltd.
Ipsen Ltd. Pharmaceuticals: MajorHealth Technology Ipsen Ltd. develops and markets medicinal products. The firm provides Decapepty, Disport, Hexvix, Increlex and Somatuline. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bioinnova | Corporate Officer/Principal | ||
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Biovector Therapeutics SA
Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ATON | Pharmaceuticals: Major | Corporate Officer/Principal | |
promed GmbH
promed GmbH Medical DistributorsDistribution Services Part of Xiamen Comfort Science & Technology Group Co., Ltd., promed GmbH sells medical equipment for nail and skin care. The company is based in Farchant, Germany. The CEO of the German company is Andreas Schuster. promed was acquired by Medisana GmbH, part of Xiamen Comfort Science & Technology Group Co., Ltd. from October 27, 2016 on August 30, 2005 for $0.71 million. | Medical Distributors | Corporate Officer/Principal | |
Syngenta Biotechnology, Inc.
Syngenta Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Syngenta Biotechnology, Inc. provides genetics research and development services and is ultimately controlled by the Government of China. The company is based in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Rhenovia Pharma SAS
Rhenovia Pharma SAS Miscellaneous Commercial ServicesCommercial Services Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Emosis SAS
Emosis SAS Miscellaneous Commercial ServicesCommercial Services Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistieken
Internationaal
Frankrijk | 10 |
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Duitsland | 2 |
Sectoraal
Health Technology | 7 |
Commercial Services | 4 |
Consumer Services | 3 |
Distribution Services | 2 |
Operationeel
Corporate Officer/Principal | 11 |
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Director of Finance/CFO | 1 |
Sterkste connecties
Insiders | |
---|---|
Frédéric Allemand | 8 |
Jean-François Pujol | 4 |
Daniel Larzul | 4 |
Jean-Paul Leon | 2 |
- Beurs
- Insiders
- Samuel Bengio
- Bedrijfsconnecties